138
Participants
Start Date
June 20, 2013
Primary Completion Date
October 24, 2014
Study Completion Date
October 27, 2017
Erlotinib
Erlotinib will be administered at a dose of 100 mg via tablet, orally, once daily in combination with alectinib to participants who progressed on alectinib alone treatment as per treating physician discretion.
Alectinib
Alectinib will be administered at a dose of 600 milligrams (mg) via capsule, orally, twice daily.
Taichung Veterans General Hospital, Taichung
Centre Hospitalier de Luxembourg, Luxembourg
Royal North Shore Hospital, St Leonards
UZ Antwerpen, Edegem
University Hospital Herlev, Herlev
Prince Charles Hospital, Chermside
Townsville General Hospital, Douglas
Samsung Medical Center, Seoul
AZ Delta (Campus Wilgenstraat), Roeselare
UZ Gent, Ghent
National Taiwan University Hospital, Taipei
Columbia University Medical Center; Department of Hematology/Oncology, New York
National Cancer Center, Gyeonggi-do
Charité Campus Virchow-Klinikum; Department of Cardiology, Berlin
Seoul National University Bundang Hospital, Gyeonggi-do
Hôpital Nord - AP-HM Marseille#; Gastroenterology and Hepatology, Marseille
Centre Francois Baclesse, Caen
Karolinska, Stockholm
Ospedale San Raffaele, Milan
Istituto Europeo Di Oncologia, Milan
Centre Georges François Leclerc; Service Pharmacie, Bp 77980, Dijon
Virginia Cancer Specialists, PC, Fairfax
LungenClinic Großhansdorf, Großhansdorf
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario Clínico San Carlos; Servicio de Oncologia, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Regional Universitario de Malaga, Málaga
Hopital Morvan, Brest
CHU de Toulouse - Hôpital Larrey, Toulouse
Florida Hospital Cancer Inst, Orlando
Irccs Centro Di Riferimento Oncologico (CRO), Aviano
Advanced Medical Specialties, Miami
Groupe Hospitalier Sud - Hôpital Haut Lévêque, Pessac
Hopital Pontchaillou - CHU de Rennes, Rennes
University of Alabama at Birmingham, Birmingham
CHU de Grenoble - Hôpital Nord; Service d'Oncologie Thoracique, Grenoble
Diakonie Kaiserswerth; Florence-Nightingale-Krankenhaus, Düsseldorf
A.O. Universitaria Di Parma, Parma
University Hospitals Case Medical Center, Cleveland
ICO Rene Gauducheau; CEC, Saint-Herblain
Mathias-Spital Rheine, Rheine
CHU Angers - Hôpital Hôtel Dieu, Angers
Hosp Clinico Univ Lozano Blesa, Zaragoza
Azienda Ospedaliera Universitaria Careggi, Florence
Klinikum Koeln-Merheim, Cologne
Ospedale Versilia, Lido di Camaiore
Presidio Ospedaliero Campo di Marte, Lucca
Lungenklinik Hemer, Hemer
Centre Oscar Lambret, Lille
Midwestern Regional Medical Center; Office of Research, Zion
Rush University Medical Center, Chicago
Washington University; Wash Uni. Sch. Of Med, St Louis
Nouvel Hopital Civil - CHU Strasbourg, Strasbourg
Centre Leon Berard, Lyon
Texas Oncology, P.A., Dallas
Cancer Care Centers of South Texas, San Antonio
Comprehensive Cancer Centers of Nevada, Henderson
UCLA Cancer Center; Premiere Oncology, A Medical Corporation, Santa Monica
Sharp Memorial Hospital, San Diego
St. Jude Heritage Healthcare, Fullerton
UC Irvine Medical Center, Orange
Coastal Integrative Cancer Care, San Luis Obispo
"FSBSI Russian Oncological Scientific Center n.a. N.N. Blokhin; Chemotherapy Departement", Moskva
National University Hospital; Investigational Medicine Unit, Singapore
Hospital Universitario La Paz, Madrid
Johns Hopkins Singapore, Singapore
Istituto Nazionale Tumori Regina Elena IRCCS, Rome
AO San Camillo Forlanini, Rome
Azienda Socio Sanitaria Territoriale Niguarda (Ospedale Niguarda Ca' Granda), Milan
Azienda Ospedaliera di Perugia Ospedale S. Maria della Misericordia, Perugia
Antoni van Leeuwenhoek Ziekenhuis, Amsterdam
Universitair Medisch Centrum Groningen, Groningen
Maastricht University Medical Centre; Afdeling Klinische Farmacie en Toxicologie, Maastricht
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System; Pharmacy, Seoul
Asan Medical Center, Seoul
Hospital General Univ. de Alicante, Alicante
Hospital del Mar, Barcelona
Hospital Universitario Quiron Dexeus, Barcelona
Hospital Clínic i Provincial de Barcelona, Barcelona
National Cheng Kung Univ Hosp, Tainan City
Aberdeen Royal Infirmary, Aberdeen
Royal Marsden Hospital;Dept of Haematology Oncology Research, London
Royal Marsden Hospital - London, London
Hoffmann-La Roche
INDUSTRY